Helen Torley Halozyme Therapeutics, Inc. (HALO) insider trading activity

HALO Quotes by TradingView

Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 666,744 shares of HALO, which is worth approximately $31.4 Million. The most recent transaction as insider was on Dec 15, 2022, when has been sold 10,000 shares (Common Stock) at a price of $57.75 per share, resulting in proceeds of $577,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 667K
1.48% 3M change
6.91% 12M change
Total Value Held $31.4 Million

Helen Torley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2022
SELL
Open market or private sale
$577,500 $57.75 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Dec 14 2022
SELL
Open market or private sale
$583,000 $58.3 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Dec 13 2022
SELL
Open market or private sale
$588,800 $58.88 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Dec 13 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Nov 17 2022
SELL
Open market or private sale
$521,500 $52.15 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Nov 17 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Nov 16 2022
SELL
Open market or private sale
$539,000 $53.9 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Nov 16 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Nov 15 2022
SELL
Open market or private sale
$543,600 $54.36 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$237,292 $34.43 p/Share
6,892 Reduced 1.16%
587,177 Common Stock
Feb 15 2022
BUY
Exercise of conversion of derivative security
-
13,092 Added 2.16%
594,069 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$508,805 $33.64 p/Share
15,125 Reduced 2.54%
580,977 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
28,729 Added 4.6%
596,102 Common Stock
Feb 12 2022
SELL
Payment of exercise price or tax liability
$590,497 $34.2 p/Share
17,266 Reduced 2.95%
567,373 Common Stock
Feb 12 2022
BUY
Exercise of conversion of derivative security
-
32,795 Added 5.31%
584,639 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$579,934 $34.94 p/Share
16,598 Reduced 2.92%
551,844 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
31,282 Added 5.22%
568,442 Common Stock
Nov 08 2021
SELL
Open market or private sale
$2,001,000 $40.02 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Nov 08 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Oct 04 2021
SELL
Open market or private sale
$2,023,000 $40.46 p/Share
50,000 Reduced 8.52%
537,160 Common Stock
Oct 04 2021
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 7.85%
587,160 Common Stock
Sep 07 2021
SELL
Open market or private sale
$2,132,000 $42.64 p/Share
50,000 Reduced 8.52%
537,160 Common Stock

Also insider at

DGX
QUEST DIAGNOSTICS INC Healthcare
Director
HT

Helen Torley

PRESIDENT AND CEO
Secaucus, NJ

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HALO